-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Ingevity, Raises Price Target to $70

Benzinga·12/10/2025 12:56:52
Listen to the news
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $64 to $70.